Biopelle was established as the aesthetics division of Ferndale Laboratories, Inc. in August of 2005 after FPG executives recognized that the aesthetic needs of the marketplace required a dedicated division and sales force. Biopelle was charged with the task of developing a unique product portfolio designed to improve the health and appearance of the skin. Biopelle began with two products from Ferndale's portfolio, LMX and OC Eight, and has continued to add new products that are unique, effective and represent cutting edge technology, including AFA, Auriderm
Biopelle is a team of individuals who are passionate about aesthetics and aesthetic medicine. Team Biopelle is committed to leading the aesthetic medical community by expanding the borders of knowledge in the rapidly growing field of aesthetics by providing research, education and innovative products and services.
In April, 2007, the Biopelle division of Ferndale Laboratories became Biopelle, Inc., an innovative, ethical aesthetic products company dedicated to products sold exclusively through physician offices, medi-spas and medical websites.